Lara McGrath

522 total citations
12 papers, 150 citations indexed

About

Lara McGrath is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lara McGrath has authored 12 papers receiving a total of 150 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lara McGrath's work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (3 papers) and Adenosine and Purinergic Signaling (2 papers). Lara McGrath is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (3 papers) and Adenosine and Purinergic Signaling (2 papers). Lara McGrath collaborates with scholars based in United States, United Kingdom and Japan. Lara McGrath's co-authors include Joseph Ayers, Steven V. Vollmer, Stefan T. Kaluziak, Wilson Cb, Levin Va, Charles G. Drake, Manish R. Patel, Todd M. Bauer, Gerald S. Falchook and Emerson A. Lim and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and BMC Genomics.

In The Last Decade

Lara McGrath

12 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lara McGrath United States 8 79 48 37 35 27 12 150
Julie Anderson United States 4 158 2.0× 20 0.4× 14 0.4× 120 3.4× 20 0.7× 5 255
Sarah Palackdharry United States 9 146 1.8× 66 1.4× 58 1.6× 135 3.9× 6 0.2× 17 312
Yajas Shah United States 7 40 0.5× 38 0.8× 42 1.1× 142 4.1× 7 0.3× 14 238
Yuki Yamamura Japan 7 47 0.6× 81 1.7× 25 0.7× 53 1.5× 11 0.4× 9 196
Marie Winandy Belgium 7 30 0.4× 18 0.4× 20 0.5× 182 5.2× 11 0.4× 11 280
Kei Ishii Japan 7 56 0.7× 27 0.6× 15 0.4× 152 4.3× 26 1.0× 8 329
Yan Qin China 7 27 0.3× 26 0.5× 31 0.8× 56 1.6× 3 0.1× 13 124
Matthew Pun United States 6 60 0.8× 24 0.5× 36 1.0× 140 4.0× 5 0.2× 9 235
Diemmy Nguyen United States 7 98 1.2× 78 1.6× 34 0.9× 37 1.1× 21 0.8× 13 181
Valentina Obino Italy 9 129 1.6× 144 3.0× 18 0.5× 88 2.5× 6 0.2× 14 283

Countries citing papers authored by Lara McGrath

Since Specialization
Citations

This map shows the geographic impact of Lara McGrath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara McGrath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara McGrath more than expected).

Fields of papers citing papers by Lara McGrath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara McGrath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara McGrath. The network helps show where Lara McGrath may publish in the future.

Co-authorship network of co-authors of Lara McGrath

This figure shows the co-authorship network connecting the top 25 collaborators of Lara McGrath. A scholar is included among the top collaborators of Lara McGrath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara McGrath. Lara McGrath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Secrier, Maria, Lara McGrath, Felicia Ng, et al.. (2023). Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma. Cancer Research Communications. 3(10). 2133–2145. 7 indexed citations
2.
3.
McGrath, Lara, Ying Zheng, Sihem Khelifa, et al.. (2023). Abstract 5737: Evaluation of the relationship between target expression and in vivo anti-tumor efficacy of AZD9592, an EGFR/c-MET targeted bispecific antibody drug conjugate. Cancer Research. 83(7_Supplement). 5737–5737. 9 indexed citations
4.
Aggarwal, Charu, Christopher G. Azzoli, Alexander I. Spira, et al.. (2023). EGRET: A first-in-human study of the novel antibody-drug conjugate (ADC) AZD9592 as monotherapy or combined with other anticancer agents in patients (pts) with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). TPS3156–TPS3156. 12 indexed citations
5.
Comer, Frank I., Yariv Mazor, Elaine M. Hurt, et al.. (2023). Abstract 5736: AZD9592: An EGFR-cMET bispecific antibody-drug conjugate (ADC) targeting key oncogenic drivers in non-small-cell lung cancer (NSCLC) and beyond. Cancer Research. 83(7_Supplement). 5736–5736. 16 indexed citations
6.
Papadopoulos, Kyriakos P., Nehal J. Lakhani, Timothy A. Yap, et al.. (2021). Phase 1, first-in-human trial of JTX-8064, an anti-LILRB2/ILT4 monoclonal antibody, as monotherapy and in combination with anti-PD-1 in adult patients with advanced solid tumors (INNATE).. Journal of Clinical Oncology. 39(15_suppl). TPS2672–TPS2672. 2 indexed citations
7.
8.
Yap, Timothy A., Justin F. Gainor, Howard A. Burris, et al.. (2020). Association of an RNA signature (RS) with emergence of ICOS hi CD4 T cells and efficacy outcomes for the ICOS agonist vopratelimab (vopra) and nivolumab (nivo) in patients (pts) on the ICONIC trial.. Journal of Clinical Oncology. 38(5_suppl). 14–14. 1 indexed citations
9.
Bendell, Johanna C., Todd M. Bauer, Manish R. Patel, et al.. (2019). Abstract CT026: Evidence of immune activation in the first-in-human Phase Ia dose escalation study of the adenosine 2a receptor antagonist, AZD4635, in patients with advanced solid tumors. Cancer Research. 79(13_Supplement). CT026–CT026. 20 indexed citations
10.
11.
McGrath, Lara, Steven V. Vollmer, Stefan T. Kaluziak, & Joseph Ayers. (2016). De novo transcriptome assembly for the lobster Homarus americanus and characterization of differential gene expression across nervous system tissues. BMC Genomics. 17(1). 63–63. 27 indexed citations
12.
Va, Levin, et al.. (1984). PCNU treatment for recurrent malignant gliomas.. PubMed. 68(7-8). 969–73. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Anderson Breakdown of academic impact, for papers by Sarah Palackdharry Breakdown of academic impact, for papers by Yajas Shah Breakdown of academic impact, for papers by Yuki Yamamura Breakdown of academic impact, for papers by Marie Winandy Breakdown of academic impact, for papers by Kei Ishii Breakdown of academic impact, for papers by Yan Qin Breakdown of academic impact, for papers by Matthew Pun Breakdown of academic impact, for papers by Diemmy Nguyen Breakdown of academic impact, for papers by Valentina Obino
Rankless by CCL
2026